Novel path to activation of vascular smooth muscle cells: Up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor

Journal of Immunology

Volumn 163, Issue 8, 1999, Pages 4583-4589

  Klouche, Mariam ^a   Bhakdi, Sucharit ^a   Hemmes, Monika ^a   Rose John, Stefan ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT REJECTION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULITIS;

AGED; ANTIGENS, CD; AUTOCRINE COMMUNICATION; CELL DIVISION; CELLS, CULTURED; CHEMOKINE CCL2; CYTOKINE RECEPTOR GP130; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MACROMOLECULAR SUBSTANCES; MALE; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; SOLUBILITY; UP-REGULATION;

EID: 0032846613     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1.
2. Taga, T., and T. Kishimoto. 1997. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:797.
3. Yamasaki, K., T. Taga, Y. Hirata, H. Yawata, Y. Kawanishi, B. Seed, T. Taniguchi, T. Hirano, and T. Kishimoto. 1988. Cloning and expression of the human interleukin-6 (BSF-2/IFN β2) receptor. Science 241:825.
4. Müllberg, J., H. Schooltink, T. Stoyan, M. Gunther, L. Graeve, G. Buse, A. Mackiewicz, P. C. Heinrich, and S. Rose-John. 1993. The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23:473.
5. Müllberg, J., F. H. Durie, C. Otten Evans, M. R. Alderson, S. Rose-John, D. Cosman, and R. A. Black, and K. M. Mohler. 1995. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J. Immunol. 155:5198.
6. Lust, J. A., K. A. Donovan, M. P. Kline, P. R. Greipp, R. A. Kyle, and N. J. Maihle. 1992. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine. 4:96.
7. Rose-John, S., and P. C. Heinrich. 1994. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300:281.
8. Romano, M., M. Sironi, C. Toniatti, N. Polentarutti, P. Fruscella, P. Ghezzi, R. Faggioni, Luini-W, V. van Hinsbergh, S. Sozzani, F. Bussolino, V. Poli, G. Ciliberto, and A. Mantovani. 1997. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:315.
9. Modur, V., Y. Li, G. A. Zimmerman, S. M. Prescott, and T. M. McIntyre. 1997. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor α. J. Clin. Invest. 100:2752.
10. Peters, M., P. Schirmacher, J. Goldschmitt, M. Odenthal, C. Peschel, E. Fattori, G. Ciliberto, H. P. Dienes, K. H. Meyer zum Büschenfelde, and S. Rose-John. 1997. Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J. Exp. Med. 185:755.
11. März, P., T. Herget, E. Lang, U. Otten, and S. Rose-John. 1997. Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation. Eur. J. Neurosci. 9:2765.
12. März, P., J. G. Cheng, R. A. Gadient, P. H. Patterson, T. Stoyan, U. Otten, and S. Rose-John. 1998. Sympathetic neurons can produce and respond to interleukin 6. Proc. Natl. Acad. Sci. USA 95:3251.
13. Udagawa, N., N. Takahashi, T. Katagiri, T. Tamura, S. Wada, D. M. Findlay, T. J. Martin. H. Hirota, T. Taga, T. Kishimoto, et al. 1995. Interleukin (ID-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J. Exp. Med. 182:1461.
14. Staels, B., W. König, A. Habib, R. Merval, M. Lebret, I.P. Torra, P. Delerive, A. Fadel, G. Chinetti, J.C. Fruchart, J. Najib, J. Maclouf, and A. Tedgui. 1998. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 393:790.
15. Stein, O., and Y. Stein. 1995. Smooth muscle cells and atherosclerosis. Curr. Opin. Lipidol. 6:269.
16. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801.
17. Ikeda, U., M. Ikeda, T. Oohara, A. Oguchi, T. Kamitani, Y. Tsuruya, and S. Kano. 1991. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am. J. Physiol. 260:H1713.
18. Roth, M., M. Nauck, M. Tamm, A. P. Perruchoud, R. Ziesche, and L. H. Block. 1995. Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells. Proc. Natl. Acad. Sci. USA 92:1312.
19. Sato, Y., R. Hamanaka, J. Ono, M. Kuwano, D. B. Rifkin, and R. Takaki. 1991. The stimulatory effect of PDGF on vascular smooth muscle cell migration is mediated by the induction of endogenous basic FGF. Biochem. Biophys. Res. Commun. 174:1260.
20. Jawien, A., D. F. Bowen Pope, V. Lindner, S. M. Schwartz, and A. W. Clowes. 1992. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89:507.
21. Wang, X., T. L. Yue, E. H. Ohlstein, C. P. Sung, and G. Z. Feuerstein. 1996. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J. Biol. Chem. 271:24286.
22. Ikeda, U., M. Ikeda, Y. Seino, M. Takahashi, T. Kasahara, S. Kano, and K. Shimada. 1993. Expression of intercellular adhesion molecule-1 on rat vascular smooth muscle cells by pro-inflammatory cytokines. Atherosclerosis 104:61.
23. Loppnow, H. 1994. LPS, recIL1 and smooth muscle cell-IL1 activate vascular cells by specific mechanisms. Prog. Clin. Biol. Res. 388:309.
24. Loppnow, H., and P. Libby. 1992. Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. Exp. Cell Res. 198:283.
25. Lindner, V., and M. A. Reidy. 1991. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 88:3739.
26. Reidy, M. A. 1993. Neointimal proliferation: the role of basic FGF on vascular smooth muscle cell proliferation. Thromb. Haemost. 70:172.
27. Li, J., M. A. Perrella, J. C. Tsai, S. F. Yet, C. M. Hsieh, M. Yoshizumi, C. Patterson, W. O. Endege, Zhou-F, and M. E. Lee. 1995. Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J. Biol. Chem. 270:308.
28. Ross, R. 1971. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J. Cell Biol. 50:172.
29. Magnier, C., B. Papp, E. Corvazier, R. Bredoux, F. Wuytack, J. Eggermont, J. Maclouf, and J. Enouf. 1992. Regulation of sarco-endoplasmic reticulum Ca(2+)-ATPases during platelet-derived growth factor-induced smooth muscle cell proliferation. J. Biol. Chem. 267:15808.
30. van Dam, M., J. Müllberg, H. Schooltink, T. Stoyan, J. P. Brakenhoff, L. Graeve, and P. C. Heinrich, and S. Rose-John. 1993. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding. J. Biol. Chem. 268:15285.
31. Vollmer, P., M. Peters, M. Ehlers, H. Yagame, T. Matsuba, M. Kondo, K. Yasukawa, K. H. Buschenfelde, and S. Rose John. 1996. Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor. J. Immunol. Methods 199:47.
32. Fischer, M., J. Goldschmitt, C. Peschel, J. P. Brakenhoff, K. J. Kallen, A. Wollmer, and J. Grotzinger, and S. Rose-John. 1997. I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat. Biotechnol. 15:142.
33. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
34. Klouche, M., S. Gottschling, V. Gerl, W. Hell, M. Husmann, B. Dorweiler, M. Messner, and S. Bhakdi. 1998. Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages. Arterioscl. Thromb. Vasc. Biol. 18:1376.
35. Wang, X.-J., T Taga, K. Yoshida, M. Saito, T. Kishimoto, and H. Kikutani. 1998. Gp130, the cytokine common signal-transducer of interleukin-6 cytokine family, is downregulated in T-cells in vitro by interleukin-6. Blood 91:3308.
36. Horiuchi, S., Y. Koyanagi, Y. Zhou, H. Miyamoto, Y. Tanaka, M. Waki, A. Matsumoto, M. Yamamoto, and N. Yamamoto. 1994. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur. J. Immunol. 24:1945.
37. Bhakdi, S., B. Dorweiler, R. Kirchmann, J. Torzewski, E. Weise, J. Tranum-Jensen, I. Walev, and E. Wieland. 1995. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J. Exp. Med. 182:1959.
38. Walev, I., P. Vollmer, M. Palmer, S. Bhakdi, and S. Rose-John. 1996. Poreforming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 93:7882.
39. Vollmer, P., I. Walev, S. Rose-John, and S. Bhakdi. 1996. Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor. Infect. Immun. 64:3646.
40. Taub, D. D., P. Proost, W. J. Murphy, M. Anver, D. L. Longo, J. van Damme, and J. J. Oppenheim. 1995. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T-lymphocytes. J. Clin. Invest. 95:1370.
41. Schall, T. J. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3:165.
42. Carr, M. W., S. J. Roth, E. Luther, S. S. Rose, and T. A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91:3652.
43. + T-lymphocytes. FASEB J. 8:1055.
44. Luo, Y., P. A. D'Amore, and M. E. Dorf 1996. β-Chemokine TCA3 binds to and activates rat vascular smooth muscle cells. J. Immunol. 157:2143.
45. Klouche, M., A. May, M. Hemmes, M. Messner, S. M. Kanse, K. T. Preissner, and S. Bhakdi. 1998. Enzymatically modified, non-oxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers. Arterioscl. Thromb. Vasc. Biol. 19:784.
46. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
47. Mensink, A., A. Brouwer, E. H. Van den Burg, S. Geurts, W. M. Jongen, C. M. Lakemond, I. Meijerman, and T. Van der Wijk. 1996. Modulation of intercellular communication between smooth muscle cells by growth factors and cytokines. Eur. J. Pharmacol. 310:73.
48. Lou, H., T. Kodama, Y. N. Wang, N. Katz, P. Ramwell, and M. L. Foegh. 1996. L-arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-I and interleukin-6. J. Heart Lung Transplant. 15:1248.
49. Loppnow, H., and P. Libby. 1990. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J. Clin. Invest. 85: 711.
50. Lavabre-Bertrand, T., C. Exprayat, J. Liautard, J. P. Gaillard, P. P. Baskevitch, N. Poujol, C. Duperray, P. Bourquard and J. Brochier. 1995. Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies. Br. J. Hematol. 91:871.
51. Brivet, F. G., D Emilie, and P. Galanaud. 1999. Pro- and antiinflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study group on acute pancreatitis. Crit. Care Med. 27:749.
52. Pickup, J. C., M. B. Mattock, G. D. Chusney, and D. Burt. 1997. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologica 40:1286.
53. Uno, H., Y. Ueki, J. Murashima, S. Miyake, Y. Tominaga, K. Eguchi, and K. Yano. 1995. Removal of LDL from plasma by absorption reduced adhesion molecules on mononuclear cells in patients with arteriolosclerosis obliterans. Atherosclerosis 116:93.